Correlation Between Armata Pharmaceuticals and Madrigal Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Armata Pharmaceuticals and Madrigal Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Armata Pharmaceuticals and Madrigal Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Armata Pharmaceuticals and Madrigal Pharmaceuticals, you can compare the effects of market volatilities on Armata Pharmaceuticals and Madrigal Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Armata Pharmaceuticals with a short position of Madrigal Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Armata Pharmaceuticals and Madrigal Pharmaceuticals.
Diversification Opportunities for Armata Pharmaceuticals and Madrigal Pharmaceuticals
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Armata and Madrigal is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Armata Pharmaceuticals and Madrigal Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Madrigal Pharmaceuticals and Armata Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Armata Pharmaceuticals are associated (or correlated) with Madrigal Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Madrigal Pharmaceuticals has no effect on the direction of Armata Pharmaceuticals i.e., Armata Pharmaceuticals and Madrigal Pharmaceuticals go up and down completely randomly.
Pair Corralation between Armata Pharmaceuticals and Madrigal Pharmaceuticals
Given the investment horizon of 90 days Armata Pharmaceuticals is expected to under-perform the Madrigal Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Armata Pharmaceuticals is 1.72 times less risky than Madrigal Pharmaceuticals. The stock trades about -0.01 of its potential returns per unit of risk. The Madrigal Pharmaceuticals is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 32,324 in Madrigal Pharmaceuticals on November 8, 2024 and sell it today you would earn a total of 703.00 from holding Madrigal Pharmaceuticals or generate 2.17% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Armata Pharmaceuticals vs. Madrigal Pharmaceuticals
Performance |
| Timeline |
| Armata Pharmaceuticals |
| Madrigal Pharmaceuticals |
Armata Pharmaceuticals and Madrigal Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Armata Pharmaceuticals and Madrigal Pharmaceuticals
The main advantage of trading using opposite Armata Pharmaceuticals and Madrigal Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Armata Pharmaceuticals position performs unexpectedly, Madrigal Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Madrigal Pharmaceuticals will offset losses from the drop in Madrigal Pharmaceuticals' long position.The idea behind Armata Pharmaceuticals and Madrigal Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Madrigal Pharmaceuticals vs. TG Therapeutics | Madrigal Pharmaceuticals vs. Terns Pharmaceuticals | Madrigal Pharmaceuticals vs. Hepion Pharmaceuticals | Madrigal Pharmaceuticals vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |